Delivery Order SPE2DB24D1205-SPE2DB25FCSZE

Award Date 1/13/25
Potential Completion Date 2/4/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,784.34 Firm Fixed Price Delivery Order is for the supply of TALZENNA 0.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of January 6, 2025 and was awarded on December 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,424.08 firm-fixed-price delivery order is for the supply of 4565190685 - TALZENNA 1 MG CAPSULE 30S, a prescription medication. This award does not utilize a set-aside and has an ultimate completion date of August 8, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,487.85 firm fixed-price contract is for the supply of TALZENNA 0.25 MG CAPSULE 30S, a pharmaceutical product, with a performance period extending through December 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of TALZENNA 1 MG CAPSULE 30S pharmaceutical products, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $20,005.92 firm fixed price delivery order contract has a completion date of March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not designated as a...
This federal contract award, with ID SPE2DB20D1051|SPE2DB24FD7YN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $20,848.16 Firm Fixed Price Delivery Order is for the supply of the pharmaceutical product Talzenna 0.5 mg capsules. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. Under this single-award...
This federal contract award, valued at $1,094.07, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract valued at $2,703.38 for the supply of 4,564,259,813 units of the pharmaceutical product JATENZO 237 MG CAPSULE 120S. The contract has a firm fixed price pricing type and an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,453.58 firm fixed-price delivery order is for the supply of TAVNEOS 10 MG CAPSULE 180S, a pharmaceutical product. The contract has an ultimate completion date of December 31, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,562.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of JATENZO 237 MG CAPSULE 120S, with an ultimate completion date of January 3, 2025. The contract is a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $95,655.40 firm fixed-price delivery order contract is for the provision of ZEPZELCA 4 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCSZE
    Delivery Order

This federal contract award, valued at $10,784.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an Ultimate Completion Date of February 4, 2025.

The contract covers the procurement of TALZENNA 0.5 MG CAPSULE 30S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military. This contract award is not designated as a set-aside.

Generated 4/14/25, 10:41 AM